Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Slager

Showing results (161-170 of 277) with videos related to

Pageof 28
Sort By:
Clinical Epidemiology|December 10, 2019
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing ChemotherapyMichael R Clausen, Matthew J Maurer, Sinna Pilgaard Ulrichsen, et al.
Blood|January 9, 2024
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signatureSalma B Abdelbaky, Brian Giacopelli, Kari G Rabe, et al.
Blood Advances|October 18, 2021
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomesAlessia Castellino, Yucai Wang, Melissa C Larson, et al.
Annals of Hematology|June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomesWilliam J Archibald, Kari G Rabe, Brian F Kabat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphomaMatthew T Drake, Matthew J Maurer, Brian K Link, et al.
Journal of the National Cancer Institute|July 1, 2010
Cigarette smoking and colorectal cancer risk by molecularly defined subtypesDavid Limsui, Robert A Vierkant, Lori S Tillmans, et al.
The American Journal of Surgical Pathology|July 23, 2015
Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based CohortRondell P Graham, Robert A Vierkant, Lori S Tillmans, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 9, 2011
Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older womenAnthony A Razzak, Amy S Oxentenko, Robert A Vierkant, et al.
Leukemia & Lymphoma|November 9, 2016
Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practiceHeidi D Finnes, Kari G Chaffee, Timothy G Call, et al.
British Journal of Haematology|August 18, 2018
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centrePaul J Hampel, Melissa C Larson, Brian Kabat, et al.
Pageof 28

Showing results (161-170 of 277) with videos related to

Sort By:
Pageof 28
Clinical Epidemiology|December 10, 2019
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing ChemotherapyMichael R Clausen, Matthew J Maurer, Sinna Pilgaard Ulrichsen, et al.
Blood|January 9, 2024
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signatureSalma B Abdelbaky, Brian Giacopelli, Kari G Rabe, et al.
Blood Advances|October 18, 2021
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomesAlessia Castellino, Yucai Wang, Melissa C Larson, et al.
Annals of Hematology|June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomesWilliam J Archibald, Kari G Rabe, Brian F Kabat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphomaMatthew T Drake, Matthew J Maurer, Brian K Link, et al.
Journal of the National Cancer Institute|July 1, 2010
Cigarette smoking and colorectal cancer risk by molecularly defined subtypesDavid Limsui, Robert A Vierkant, Lori S Tillmans, et al.
The American Journal of Surgical Pathology|July 23, 2015
Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based CohortRondell P Graham, Robert A Vierkant, Lori S Tillmans, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 9, 2011
Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older womenAnthony A Razzak, Amy S Oxentenko, Robert A Vierkant, et al.
Leukemia & Lymphoma|November 9, 2016
Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practiceHeidi D Finnes, Kari G Chaffee, Timothy G Call, et al.
British Journal of Haematology|August 18, 2018
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centrePaul J Hampel, Melissa C Larson, Brian Kabat, et al.
Pageof 28